-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label_executive.pdf
January 01, 2007 - Layout 1
Background
Aripiprazole, olanzapine, quetiapine,
risperidone, and ziprasidone are atypical
antipsychotics approved by the U.S. Food
and Drug Administration (FDA) for
treatment of schizophrenia and bipolar
disorder. These drugs have been studied for
off-label use in the following conditions:
dementia and seve…
-
effectivehealthcare.ahrq.gov/sites/default/files/reporting.ppt
September 01, 2009 - There were no deaths reported in the three respiratory syncytial virus/severe bronchiolitis trials; thus … than PSA [prostate-specific antigen] testing and treated with radical prostatectomy experienced fewer deaths … from prostate cancer, marginally fewer deaths from any cause, and fewer distant metastases.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_disposition-comments.pdf
August 12, 2016 - Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review
Source: https://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/
?pageaction=displayproduct&productid=2261
Published Online: August 12, 2016
Evidence Report/Technology Assessment Disposition of Comments Report
Re…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_disposition-comments.pdf
November 27, 2012 - with a 0.5%
perioperative mortality (the
largest series of patients with
HCV infection found no deaths … “HCV infection… associated with an estimated 12,000 deaths each
year in the United States.” … The largest study of HCV
patients showed no deaths. … Mortality is 12,000 deaths per year. … in 2010 could reduce the risk of
cirrhosis, liver decompensation, liver cancer, and liver related deaths
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/sleep-apnea_executive.pdf
July 01, 2011 - perioperative death in about 1.5% in
Surgery vs. control two studies of UPPP—though most studies reported no deaths
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-pain_research-protocol.pdf
August 05, 2010 - In the United States, there are an
estimated 16,500 annual deaths due to NSAID-induced gastrointestinal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/vaccine-safety_research-protocol.pdf
September 18, 2012 - there were nearly
12,000 new cases of cervical cancer reported, with 4,000 cervical cancer-related deaths
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-221-copd-comments.pdf
October 11, 2019 - CER 221 Disposition of Comments: Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Pharmacologic and Nonpharmacologic Therapies in Adult Patients
With Exacerbation of COPD: A Sy…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-221-copd-comments_0.pdf
October 11, 2019 - CER 221 Disposition of Comments: Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Pharmacologic and Nonpharmacologic Therapies in Adult Patients
With Exacerbation of COPD: A Systematic Rev…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_executive.pdf
April 01, 2013 - 1
Epoetin and Darbepoetin for Managing
Anemia in Patients Undergoing Cancer
Treatment: Comparative Effectiveness Update
Executive Summary
Background
Anemia, a deficiency in the concentration
of hemoglobin-containing red blood
cells, is prevalent among cancer patients,
depending on the type of malignancy
and t…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
April 01, 2013 - placebo
SOE = Insufficient
(6 studies, 838 patients)
Inconclusive benefit (few
studies, few deaths … placebo
SOE = Insufficient
(4 studies, 1,011 patients)
Inconclusive benefit (few
studies, few deaths … monotherapy
SOE = Insufficient
(3 studies, 566 patients)
Inconclusive benefit (few
studies, few deaths … Few deaths were observed in these limited-duration
studies, leading to wide confidence intervals and
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/risk-cardiovascular-disease.pdf
January 01, 2023 - Recent trends in cardiovascular disease
deaths: a state specific perspective.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_executive.pdf
March 01, 2011 - new studies were generally of short duration (less than
1 year) and had few long-term events (such as deaths … We recommend that studies consistently report the
number of deaths in each study arm, even if there
were … Low Many RCTs were of short duration (less than 1 year) and had few deaths, limiting
the precision of
-
effectivehealthcare.ahrq.gov/products/outcomes-nutrition/protocol
December 01, 2020 - Current Page Topic Timeline Nov. 30, 2020 Topic Initiated Dec. 1, 2020 Research Protocol Maternal and Childhood Outcomes Associated With the Special Supplemental Nutrition Program for Women, Infants and Children (WIC)
Research Protocol December 1, 2020 Download Main Document PDF 484.1 KB
This protoc…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/acs-depression-research-protocol-amended.pdf
February 15, 2017 - is
the leading cause of death for both men and women, heart disease accounts for more than
600,000 deaths … annually, or 23.5% of deaths from all causes.2 Over 25 million adults in
the United States are currently … Deaths: Leading Causes for
2013. NVSR Volume 65, Number 2. 95 pp. (PHS) 2016-1250.
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_10-user-guide-to-ocer_130129.pdf
January 01, 2011 - 135
Abstract
This chapter provides a high-level overview of statistical analysis considerations for observational
comparative effectiveness research (CER). Descriptive and univariate analyses can be used to assess
imbalances between treatment groups and to identify covariates associated with exposure and/or the stu…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/topic-brief2-opioid-withdrawal.pdf
April 01, 2021 - pain intensity in some patients, it is also
associated with adverse effects, morbidity, and overdose deaths … Associations between stopping prescriptions
for opioids, length of opioid treatment, and
overdose or suicide deaths … coping with an opioid and substance use disorders crisis that
involves shifting “waves” of overdose deaths
-
effectivehealthcare.ahrq.gov/sites/default/files/schwitzer_eccs2012.pdf
July 23, 2012 - Mount Sinai School of Medicine in [New York],
said he thinks the new guidelines could cause unnecessary deaths
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_research-protocol.pdf
April 20, 2015 - known that
kidney cancer affects approximately 65,000 new patients each year with more than 13,000 deaths … most lethal, with approximately 35% of patients dying within 5 years of diagnosis.[8]
However, the deaths … Given the increased incidence in early, low-stage tumors without improvement in cancer-related
deaths
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_6-user-guide-to-ocer_130129.pdf
October 30, 2012 - 71
Abstract
This chapter provides an overview of considerations for the development of outcome measures
for observational comparative effectiveness research (CER) studies, describes implications of the
proposed outcomes for study design, and enumerates issues of bias that may arise in incorporating the
ascertainme…